ClearPoint Neuro (CLPT)
NASDAQ:CLPT
US Market

ClearPoint Neuro (CLPT) Financial Statements

254 Followers

ClearPoint Neuro Financial Overview

ClearPoint Neuro's market cap is currently ―. The company's EPS TTM is $-0.832; its P/E ratio is -8.88; ClearPoint Neuro is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 7.64M$ 6.81M$ 5.76M$ 5.95M$ 5.43M
Gross Profit$ 4.53M$ 4.01M$ 3.27M$ 5.95M$ 3.20M
EBIT$ -4.26M$ -4.71M$ -4.91M$ -7.13M$ -5.61M
EBITDA$ -4.00M$ -4.28M$ -4.74M$ -7.02M$ -5.54M
Net Income Common Stockholders$ -4.15M$ -4.62M$ -4.81M$ -7.05M$ -5.61M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 35.40M$ 23.10M$ 24.30M$ 26.50M$ 31.70M
Total Assets$ 53.64M$ 42.66M$ 43.84M$ 47.68M$ 50.25M
Total Debt$ 13.90M$ 13.94M$ 14.01M$ 14.27M$ 11.86M
Net Debt$ -21.50M$ -9.16M$ -10.29M$ -12.23M$ -19.84M
Total Liabilities$ 19.05M$ 21.49M$ 19.74M$ 20.23M$ 17.67M
Stockholders Equity$ 34.58M$ 21.17M$ 24.09M$ 27.44M$ 32.58M
Cash Flow-
Free Cash Flow$ -3.80M$ -1.29M$ -2.04M$ -5.57M$ -5.82M
Operating Cash Flow$ -3.80M$ -1.10M$ -1.80M$ -5.08M$ -5.68M
Investing Cash Flow-$ -188.00K$ -235.00K$ 9.51M$ -138.00K
Financing Cash Flow$ 16.05M$ 155.00K$ -91.00K$ 237.00K$ -5.00K
Currency in USD

ClearPoint Neuro Earnings and Revenue History

ClearPoint Neuro Debt to Assets

ClearPoint Neuro Cash Flow

ClearPoint Neuro Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis